Abstract
Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. The 5-year survival rate of metastatic RCC is only 10%. This study aimed to investigate the expression of stem cell markers (OCT4 and CD133) and annexin A1 (ANXA1) in RCC and their relations to clinicopathological parameters and Ki-67. Materials and methods OCT4, CD133, ANXA1, and Ki-67 expressions were examined immunohistochemically in RCC specimens from 57 patients. Results High CD133 expression in RCC was significantly associated with grades 1and 2 (P=0.001), pT1 and pT2 (P Conclusion A positive significant correlation of OCT4, CD133, and ANXA1 expressions with the important prognostic pathological features in RCC was found. Moreover, ANXA1 is suggested to have a role in survival of cancer stem cells. Thus, these markers may in future become important biomarkers for progression of RCC and may help in stratification of treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.